Hypertension in insulin-dependent diabetes: Epidemiological, familial, extrarenal and pathophysiological aspects of hypertension in IDDM patients with and without diabetic nephropathy

Danish Medical Bulletin

Volumn 43, Issue 1, 1996, Pages 21-38

  Nørgaard, Kirsten ^a,b  

^a STENO DIABETES CENTER   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ISRADIPINE; LISINOPRIL; NIFEDIPINE; PERINDOPRIL;

DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROTEINURIA; REVIEW;

DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; HUMANS; HYPERTENSION, RENAL;

EID: 0030048227     PISSN: 09078916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (200)

1. Allen T, Cooper M, Skinner S, Winikoff J. Doyle A, Jerums G. Elevated total renin precedes microalbuminuria in Type 1 and Type 2 diabetic patients. Third international symposium on hypertension associated with diabetes mellitus 1991; A24.
2. Amemiya S, Ishihara T, HigashidaK. Kusano S, Ohyama K, Kato K. Altered synthesis of renin in patients with insulin-dependent diabetes: plasma prorenin as a marker predicting the evolution of nephropathy. Diabetes Res Clin Pract 1990; 10: 115-122.
3. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study Diabetologia 1983; 25: 496-501.
4. Anderson S, Rennke Hu, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in rats. J Clin Invest 1986; 77: 1993-2000.
5. Anderson S, Brenner BM. Influence of antihypertensive therapy on develop-ment and progression of diabetic glomerulopathy. Diabetes Care 1988; 11: 846-849.
6. Aronson PS, Red cell sodium-lithium countertransport and essential hypertension. N Engl J Med 1982; 307: 317.
7. Bank N, Klose R, Aynedjian HS, Nguyen D, Sablay LB. Evidence against increased glomerular pressure initiating diabetic nephropathy. Kidney Int 1987; 31: 898-905.
8. Barry J, Mead K, Nabel EG, Rocco MB, Campbell S, Fenton T. Mudge GH, Selwyn AP. Effect of smoking on the activity of ischaemic heart disease. JAMA 1989; 261: 398-402.
9. Berkman J, Rifkin H. Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson). Report of a case. Metabolism 1973; 22: 715-722.
10. Björck S, Delin K. Herlitz H, Larsson O, Aurell M. Renin secretion in advanced diabetic nephropathy. Scand J Urol and Nephrol 1984; 79: 53-56.
11. Björck S, Mulec H, Johnsen SA, Norden G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy. Br Med J 1992; 304: 339-343.
12. Blaustein MP. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol 1977; 232: 165-173
13. Boneu B, Abbal M. Plante J, Bierme R. Factor VIII complex and endothelial damage Lancet 1975; i: 1430.
14. Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. Br Med J 1987; 294: 1651-1654.
15. Borch-Johnsen K. The prognosis of insulin-dependent diabetes mellitusan epidemiological approach. Dan Med Bul 1989; 36: 336-349.
16. Borch-Johnsen K, Nørgaard K, Hommel E. Mathiesen ER, Jensen JS, Deckert T, Parving H-H. Is diabetic nephropathy an inherited complication? Kidney Int 1992:41:719-722.
17. Brenner BM, Humes HD. Mechanics of glomerular ultrafiltration. N Engl J Med 1977; 297: 148-154.
18. Burg MB. Renal sodium handling of sodium, chloride, water amino acids and glucose In: Brenner BM. Rector FC, eds The Kidney. Saunders 1981: 328-370.
19. Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC. Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 1980; 302: 772-776.
20. Canessa M, Zerbini G, Laffel LMB. Sodium activation kinetics of red blood cell Na/Li countertransport in diabetes: methodology and controversy. J Am Soc Nephrol 1992; 3: 41-49.
21. Carr SJ, Thomas TH, Wilkinson R. Erythrocyte sodium-lithium countertransport in primary and renal hypertension. relation to family history. Eur J Clin Invest 1989; 19: 101-106.
22. Carr S, Mbanya J-C, Thomas T, Keavey P, Taylor R, Alberti KGMM, Wilkinson R. Increase in glomerular filtration rate in patients with insulindependent diabetes and elevated erythrocyte sodium-lithium countertransport. N Engl J Med 1990: 322: 500-505.
23. Chavers BM, Bilous RW, Ellis EN, Steffes MW. Mauer SM. Glomerular lesions and urinary albumin excretion in Type 1 diabetes without overt proteinuria. N Engl J Med 1989; 320: 966-970.
24. Christensen CK, Mogensen CE. Antihypertensive treatment: long-term reversal of progression of albuminuria in incipient diabetic nephropathy A long study of renal function. J Diab Compl 1987; 1: 45-52.
25. Christensen CK. The pre-proteinuric phase of diabetic nephropathy. Dan Med Bull 1991; 38: 145-159
26. Christiansen JS. On the pathogencsis of the increased glomerular filtration rate in short-term insulin-dependent diabetes Dan Med Bull 1984; 31: 349-361.
27. Chnstiansen JS. Glomerular hyperfiltration in diabetes mellitus. Diabetic Medicine 1985; 2: 235-239.
28. Christheb AR, Janka H-U, Kraus B, Gleason RE, Icasas-Cabral EA, Aiello LM, Cabrai BV, Solano A. Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects Diabetes 1976; 25: 268-274.
29. Christlieb AR, Warram JH, Krolewski AS. Busick EJ, Ganda OP. Asmal AC, Soeldner JS, Bradly RF. Hypertension: The major risk factor in juvenileonset insulin-dependent diabetics. Diabetes 1981; 30 (suppl.2): 90-96.
30. Coonrod BA, Ellis D, Becker DJ, Bunker CH, Kelsey SF, Lloyd CE, Drash AL, Kuller LH, Orchard TJ. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh epidemiology of diabetes complication study. Diabetes Care 1993; 16: 1376-1383.
31. Damsgaard E, Frøand A, Jørgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300: 297-300.
32. DCCT Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes. N Engl J Med 1993; 329: 977-986.
33. DeChatel R, Weidmann P, Hammer J, Ziegler WH, Beretta-Piccoli C, Vetter W, Reubi FC Sodium, renin, aldobterone, catecholamines, and blood pressure in diabetes mellitus. Kidney Int 1977; 12: 412-421.
34. Decken T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirtyone. Diabetologia 1978; 14: 363-370.
35. Decken T, Poulsen JE. Diabetic nephropathy: Fault or destiny? Diabetologia 1981,21: 178-183.
36. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-226
37. Decken T, Kofoed-Enevoldsen A, Nørgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T. Microalbuminuria. Implications for micro- and macrovascular disease. Diabetes Care 1992; 15: 1181-1191.
38. Decken T, Kofoed-Enevoldsen A, Vidai P, Nørgaard K, Andreasen HB, Feldt-Rasmussen B: Size- and charge selectivity of glomerular filtration in IDDM patients with and without albuminuria. Diabetologia 1993; 36: 244-251.
39. Deen WM, Satvat B. Determinants of the glomerular filtration of proteins. Am J Physiol 1981; 241: 162-170.
40. DeFronzo RA, Goldberg M, Agus ZS. The effects of glucose and insulin on renal electrolyte transport. J Clin Invest 1976; 58: 83-90.
41. DeFronzo RA. The effect of insulin on renal sodium metabolism. A review with clinical implications. Diabetologia 1981; 21: 165-171.
42. Demarie BK, Bakris GL. Effects of different calcium antagonists on proteinuna associated with diabetes mellitus. Ann hit Med 1990; 113: 987-988.
43. Ditzel J, Lervang H-H, Brøchner-Mortensen J. Renal sodium metabolism in relation to hypertension in diabetes. Diabete Metabol 1989; 15: 292-295.
44. Doyle AE. Comparison between perindopril and nifedipine in hypertensive diabetics with microalbuminuria. Melbourne Diabetic Nephropathy Study Group. Br Med J 1991; 302: 210-215.
45. Drury PL. Diabetes and arterial hypertension. Diabetoiogia 1983; 24: 1-9.
46. Drury PL, Schmith GM, Ferriss JB. Increased vasopressor responsiveness to angiotensin II in uncomplicated type 1 (insulin-dependent) diabetes. Diabetologia 1984; 27: 174-179.
47. Drury PL, Tarn AC. Are the WHO criteria for hypertension appropriate in young insulin-dependent diabetics? Diabetic Med 1985a; 2: 79-82.
48. Drury PL, Bodansky HJ. The relationship of the renin-angiotensin system in type 1 diabetes to microvascular disease. Hypertension 1985 b; 7 (suppl 2): 84-89.
49. Duntas L, Keck FS, Haug C, Hetzel W, Wolf CF, Rosenthal J, Pfeiffer EF. Serum angiotensin-converting enzyme activity and active renin plasma concentrations in insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1992; 16: 203-208.
50. Earle K, Walker J, Hill C, Viberti GC. Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1992; 326: 673-677.
51. Elving LD, Wetzels JFM, de Nobel E, Berden JHM. Erythrocyte sodium-lithium countertransport is not different in type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 1991; 34: 126-128.
52. Feldt-Rasmussen B, Borch-Johnsen K, Mathiesen ER. Hypertension in diabetes as related to nephropathy. Hypertension 1985a; 7: 18-20.
53. Feldt-Rasmussen B. Baker L, Deckert T. Exercise as aprovocative test in early renal disease in type 1 (insulin-dependent) diabetes: albuminurie, systemic and renal haemodynamic responses. Diabetologia 1985b; 28: 389-396.
54. Feldt-Rasmussen B. Increased transcapillary rate of albumin in type 1 (insulindependent) diabetic patients with microalbuminuria. Diabetologia 1986a; 29: 282-286.
55. Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986b;ii: 1300-1304.
56. Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christensen NJ, Nielsen MD. Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 610-617.
57. Fogo A, Yoshida Y, Glick AD, Homma T, Ichikawa I. Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 1988; 82: 322-330.
58. Franken AAM, Derkx FHM, Blankestijn PJ, Janssen JAMJL, Mannesse CK, Hop W, Boomsma F, Weber R, Peperkamp E, De Jong PTVM, Schalekamp MADH. Plasma proremn as an early marker of microvascular disease in patients with diabetes inellkus. Diabete Metab 1992; 18: 137-143.
59. Fuller JH. Epidemiology of hypertension associated with diabetes mellitus. Hypertension 1985, 7 (supppl II): 3-7.
60. Hall JS, Coleman TG, Mizelle HL. Does chronic hyperinsulinemia cause hypertension? Am J Hypertens 1989; 2: 171-173.
61. Hansen KW. Pedersen MM, Marshall SM, Christiansen JS, Mogensen CE. Orcadian variation of blood pressure in patients with diabetic nephropathy. Diabetologia 1992a; 35: 1074-1079.
62. Hansen KW, Pedersen MM, Christensen CK, Schmitz A, Chnstiansen JS. Mogensen CE. Normoalbuminuria ensures no reduction of renal function in type 1 (insulin-dependent) diabetic patients. J Int Med 1992b; 232: 161-167.
63. Hanssen KF, Bangstad U-J, Brinchmann-Hansen O, Dahl-Jørgensen K. Blood glucose control and diabetic microvascular complications: Longterm effects of near-normoglycaemia. Diabetic Med 1992; 9: 697-705.
64. Hardman TC, Dubrey SW, Leslie DG, Hafiz M, Noble MI, Lant AF. Erythrocyte sodium-lithium countertransport and blood pressure in identical twin pairs discordant for insulin dependent diabetes. Br Med J 1992; 305: 215-219.
65. Holdaas H, Hartmann A, Lien MG, Nilsen L, Jervell J, Fauchald P, Endresen L, Djøseland O, Berg KJ. Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy J Int Med 1991; 229: 163-170.
66. Hommel E, Parving H-H, Malinesen E, Edsberg B, Nielsen MD, Giese J. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 1986; 293: 467-470.
67. Hommel E, Mathiessen ER, Giese J, Nielsen MD, Schutten HJ. Parving H-H. On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy. Scand J Clin Lab Invest 1989; 49: 537-544.
68. Hommel E. Impact of hypertension and anuhypertensive treatment on kidney function in diabetic nephropathy Dan Med Bul 1994; 41: 167-178.
69. Hostetter TH, Renneke HG, Brenner BM. The case forintrarenal hypertension in the inilialion and progression of diabetic and other glomerulopathies. Am J Med 1982; 72: 375-380.
70. Hostetter TH. Diabetic nephropathy. Metabolic versus hemodynamic considerations. Diabetes Care 1992; 9: 1205-1215.
71. Huot SJ, Aronson PS. Na+-H4- exchanger and its role in essential hypertension and diabetes mellitus. Diabetes Care 1991; 14: 521-535.
72. Ibsen H. Renin-angiotensin systemets funktionelle betydning ved essentiel hypertension. Kpbenhavn 1981.
73. Jensen T, Borch-Johnsen K, Deckert T. Changes in blood pressure and renal function in patients with Type 1 (insulin-dependent) diabetes mellitus prior to clinical nephropathy. Diabetes Research 1987a; 4: 159-162.
74. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, DeckenT. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 1987b; 30: 144-148.
75. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Decken T Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989a; i: 461-463.
76. Jensen T. Increased plasma concentration of von Willebrand factor in insulin dependent diabetics with incipient nephropathy. Br Med J 1989b; 27-28.
77. Jensen T. Albuminuria- a marker of renal and generalized vascular disease in insulin-dependent diabetes mellitus. Dan Med Bul 1991; 38: 134-144.
78. Jensen JS, Mathiesen ER. Nørgaard K, Hommel E, Borch-Johnsen K. Funder J, Brahm J, Parving H-H and Deckert T. Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia 1990; 33: 619-624.
79. Jones SL, Wiseman MJ, Viberti GC, Keen H. Glomerular hyperfiltration and albuminuria- a 5 year prospective study in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 536A.
80. Jones SL. Trevisan R, Tariq T, Semplicini A, Mattock M, Walker JD. Nosadini R, Viberti G. Sodium-lithium countertransport in microalbummuric insulindependent diabetic patients. Hypertension 1990; 15: 570-575.
81. Kannel WB. Role of blood pressure in cardiovascular morbidity and mortality. Progress in cardiovascular disease. 1974; 17: 5-24.
82. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993; 118: 129-138.
83. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. Wisconsin Epidemiological Study of Diabetic Retinopathy.III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or less years. Arch Ophthalmol 1984; 102: 527-532.
84. Klein R, Klein BEK, Moss SE, Davis MD, DeMels DL Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med 1989; 149: 2427-2432.
85. Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Decken T Declining incidence of persistent proteinuria in type 1 (insulin-dependent) diabetic patients in Denmark. Diabetes 1987a; 36: 205-209.
86. Kofoed-Enevoldsen A, Jensen T, Borch-Johnsen K, Deckert T. Incidence of retinopathy in type 1 (insulin dependent) diabetes: Association with clinical nephropathy. J Diab Compl 1987b; 1: 96-99.
87. Kohner EM. Diabetic retinopathy. Br Med J 1993; 307: 1195-1199.
88. Krasnik A, Sælan H, Kempinski R. Lokatsamfundsmedicin i den primære sundhedstjeneste. 11. Blodtryksfordelingen som risikofaktor. En lokalsamfundsdiagnose. Ugeskr Læger 1979; 1: 45-51.
89. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR. The changing natural history of nephropathy in type 1 diabetes Am J Med 1985: 78: 785-794.
90. Krolewski AS, Canessa M. Warram JH, Laffel LMB, Christlieb R, Knowler WC. Rand LI. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 140-145.
91. Krusell LR, Jespersen LT, Schmilz A, Thomsen K, Pedersen OL. Repetitive natnuresis and blood pressure. Long-tenu calcium entry blockade with isradipine. Hypertension 1987; 10: 577-581.
92. Leenhardt L, Grigresso C, Fontbonne A, Bruzzo F, Tchobroutsky G. Blood pressure and mild background retinopathy in Type 1 (insulin-dependent) diabetic patients without hypertension. In press Diabetes Care 1994.
93. Lervang H-H, Jensen S, Brøchner-Mortensen J, Ditzel J. Farly glomerular hyperfiltration and the development of late nephropaty in type 1 (insulindependent) diabetes mellitus. Diabetologia 1988; 31: 723-729.
94. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD and the collaborative study group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993; 329: 1456-1462.
95. Lieberman J, Sastre A. Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med 1980, 93: 825-826,
96. Lijnen P, Fenyvesi A, Bex M, Bouillon R, Amery A. Erythrocyte cation transport systems and membrane lipids in insulin-dependent diabetics. Am J Hypertens 1993; 6: 763-770.
97. Lind B, Jensen T, Feldt-Rasmussen B, Decken T. Normal urinary albumin excretion in recently diagnosed type 1 diabetic patients. Diabetic Med 1989; 6: 682-684.
98. Lopes de Faria JB, Jones SL, MacDonald FA, Ferreira SR, Hill C, Messent J, Mattock M, Viberti GC. Sodium-lithium countertransport, insulin resistance and hyperlipidaemia in diabetics. Diabetologia 1990; 33: A2.
99. Luetscher JA, Kraemer FB, Wilson DM, Schwartz HC, Bryer-Ash M. Increased plasma inactive renin in diabetes mellitus: a marker of microvascular complications. N Engl J Med 1985; 312: 1412-1417.
100. Mandarine LJ. Current hypotheses for the biochemical basis of diabetic retinopathy. Diabetes Care 1992, 15: 1892-1901.
101. Mangih R, Bending JJ, Scott G, Li LK, Gupta A, Viberti GC. Increased sodiumhthium countertransport activity in red cells of patients with insulindependent diabetes and nephropathy. N Engl J Med 1988; 318: 146-150.
102. Marre M, Leblanc H, Suarez L, Guyenne T-T, Menard J, Passa P. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J 1987; 294: 1448-1452.
103. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361662 men. Lancet 1986; ii: 933-936.
104. Mathiesen ER, Oxenball B, Johansen K, Svendsen PA, Decken T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984; 26: 406-410.
105. Mathiesen ER, Borch-Johnsen K. Jensen DV, Decken T. Improved survival in patients with diabetic nephropathy. Diabetologia 1989; 32: 884-886.
106. Mathiesen ER, Rønn B, Jensen T, Storm B, Decken T. Relationship between blood pressure and albumin excretion in development of microalbuminuria. Diabetes 1990; 39: 245-249.
107. Mathiesen ER, Hommel E, Giese J, Parving H-H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 1991; 303: 81-87.
108. Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson JD, Mellows S, Miller GJ, North WRS, Stirling Y. Thompson SG. Haemostatic function and iscaemic heart disease: principal results of the Northwick park heart study. Lancet 1986; ii: 533-537.
109. Medical Research Council Working Party MRC trial of treatment of mild hypertension: principal results. Br Med J 1985; 291: 97-104.
110. Microalbuminuria Collaborative Study Group, United Kingdom. Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Br Med J 1993; 306: 1235-1239.
111. Mimran A. Insua A, Ribstem J, Bringer J, Monnier L. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy Diabetes Care 1988; 11: 850-853.
112. Misbin RI, Grant MB, Pecker MS, Atlas SA. Elevated levels of plasma prorenin (inactive renin) in diabetic and non-diabetic patients with autonomie dysfunction. J Clin Endocrinol Metab 1987; 64: 964-968.
113. Mogensen CE. Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand J Clin Lab Invest 1976; 36: 383-388
114. Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy Br Med J 1982; 285: 685-688.
115. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulindependent patients. N Engl J Med 1984. 311 : 89-93.
116. Mogensen CE, Chachati A, Christensen CK, Deckert T, Hommel E, Kastrup J, Lefevre P, Mathiesen ER, Feldt-Rasmussen B, Schmitz A. Microalbuminuria, an early marker of renal involvement in diabetes. Uremia Invest 1986a; 9: 85-95.
117. Mogensen CE. Early glomerularhyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Clin Invest 1986b; 46: 201-206.
118. Mogensen CE, Hansen KW, Pedersen MM, Christensen CK. Renal factors influencing blood pressure threshold and choice of treatment for hypertension in IDDM. Diabetes Care 1991; 14 (suppl 4): 13-26.
119. Molitz ME, Steffes MW, Cleary PA, Nathan DM. Baseline analysis of renal function in the diabetes control and complications trial. Kidney Int 1993, 43: 668-674.
120. Moore RD. Stimulation of Na-H exchange by insulin. Biophys J 1981; 33: 203-210.
121. Moore WV, Donaldson DL, Chonko AM, Ideus P, Wiegmann TB. Ambulatory blood pressure in Type 1 diabetes mellitus. Comparison to presence of incipient nephropathy in adolescents and young adults Diabetes 1992; 41: 1035-1041.
122. Morelli E, Loon N, Meyer T Peters W, Myers BD. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990; 39: 76-82.
123. Mulec H, Johnsen SA, Björck S. Long-term enalapril treatment in diabetic nephropathy. Kidney Int 1994; 45 (suppl 45): 141-144.
124. Najarian JS, Chavers BM, McHugh LE, Matas AJ. 20 years or more of follow-up living kidney donors. Lancet 1992; 340: 807-810.
125. Norvick AC, Gephardt G, Guz B, Steinmuller D, Tubbs RR. Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 1991; 325: 1058-62.
126. Nyberg G, Andersson C, Persson H, Østerby R. Twenty years of hyperfiltration without diabetic-type glomerulosclerosis. Am J Kidney Dis 1989; 13: 345-347.
127. Nørgaard K, Feldt-Rasmussen B, Borch-Johnsen K, Sœlan H, Deckert T. Prevalence of hypertension in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 407-410.
128. Nørgaard K, Feldt-Rasmussen B, Deckert T. Is hypertension a major independent risk factor for retinopathy in Type 1 diabetes? Diabetic Med 1991a; 8: 334-337.
129. Nørgaard K, Mathiesen ER, Hommel E, Jensen JS, Parving H-H. Lack of familial predisposition to cardiovascular disease in Type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetotogia 1991b; 34: 370-372.
130. Nørgaard K, Jensen T, Skøtt P, Thorsteinsson B, Bruun NE, Giese J, Feldt-Rasmussen B Effects of insulin on renal haemodynamics and sodium handling in normal subjects. Scand J Clin Lab Invest 1991c; 51: 367-376.
131. Nørgaard K, Jensen T, Feldt-Rasmussen B. Effects of isradipine in Type 1 (insulin-dependent) diabetic patients with albuminuria and normal blood pressure. J Human Hypertens 1992; 6: 145-150.
132. Nørgaard K, Rasmussen E, Jensen T, Giese J, Feldt-Rasmussen B. Nature of elevated blood pressure in normoalbuminuric Type 1 diabetic patients. Essential hypertension? Am J Hypertens 1993a; 6: 830-836.
133. Nørgaard K, Jensen T, Feldt-Rasmussen B. Transcapillary escape rate of albumin in hypertensive patients with insulin-dependent diabetes. Diabetologia 1993b; 36: 57-61.
134. Nørgaard K, Jensen T, Feldt-Rasmussen B. A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension Blood Pressure 1993c; 2: 301-308.
135. Nørgaard K, Feldt-Rasmussen B. Sodium retention and insulin-treatment in insulin-dependent diabetes mellitus. Acta Diabetol 1994; 31: 19-25.
136. O'Donnell MJ, Lawson N, Barnett AH. Activity of the unstimulated reninangiotensin-aldosteron system in Type 1 diabetic patients with and without proteinuna. Diabetic Med 1989; 6: 422-425.
137. O'Hare JA, Ferriss JB, Twomey B, O'Sulbvan J. Poor metabolic control, hypertension and microangiopamy independently increase the transcapillary escape rate of albumin in diabetes. Diabetologia 1983; 25: 260-263.
138. O'Hare JA, Ferriss JB, Brady D, Twomey B, O'Sullivan DJ. Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension 1985; 7: 43-48.
139. O'Hare JP, Roland JM, Walthers G, Corrall RJM. Impaired sodium excretion in response to volume expansion induced by water immersion in insulindependent diabetes mellitus. Clin Sci 1986; 71: 403-409.
140. O'Hare JP, Anderson JV, Millar ND, Bloom SR, Corrall RJM. The relationship of the renm-angiotension-aldosterone system to atrial natriuretic peptide and the natriuresis of volume expansion in diabetics with and without proteinuria. Postgrad Med J 1988; 64 (suppl 3): 35-38.
141. Ohata I, Sakamoto N, Sagano K, Maeno H. Low density lipoprotein-lowering and high density lipoprotem-elevating effects of nicardipine in rats. Biochein Pharmacol 1984; 33: 2199-2205.
142. Ortola FV, Ballermann BJ, Anderson S, Mendez RE, Brenner BM. Elevated plasma atrial natriuretic peptide levels in diabetic rats. J Clin Invest 1987; 80: 670-674.
143. Parving H-H, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res 1973; 32: 643-651.
144. Parving H-H, Mogensen CE, Jensen HÆ, Evrin P-E. Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974; i: 1190-1192.
145. Parving H-H. Microvascular permeability to plasma proteins in hypertension and diabetes mellitus in man - on the pathogenesis of hypertensive and diabetic microangiopathy. Dan Med Bull 1975; 22; 6: 217-233.
146. Parving H-H, Noer I, Deckert T, Evrin P-E, Nielsen SL, Lyngsøe J, Mogensen CE, Rørth M, Svendsen PA, Trap-Nielsen J, Lassen NA. The effect of metabolic regulation on microvascular permeability to small and large molecules in shortterm juvenile diabetics. Diabetologia 1976; 12: 161-166.
147. Parving H-H, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR. A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetic patients with diabetic nephropathy. Diabetologia 1981; 20: 457-461.
148. Parving H-H, Oxenbøll B, Svendsen PAa, Christiansen JS, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol 1982; 100: 550-555.
149. Parving H-H, Andersen AR, Smidt UM, Svendsen PA. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983; i: 1175-1179.
150. Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 1987; 294: 1443-1447.
151. Parving H-H, Hommel E, Nielsen MD, Giese J. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. Br Med J 1989a; 299: 533-536.
152. Parving H-H, Hommel E, Mathiesen E, Skøtt P, Edsberg B, Bahnsen M, Lauritsen M, Hougaard P, Lauritzen E. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J 1989b; 296: 156-16.
153. Parving H-H, Larsen M, Hommel E, Lund-Andersen H. Effect of antihypertensive treatment on blood-retinal barrier permeability to flourescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia 1989c; 32: 440-444.
154. Parving H-H, Hommel E. Prognosis in diabetic nephropathy. Br Med J 1989d; 299: 230-233.
155. Parving H-H. Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus. Diabetes Care 1991; 14: 260-269.
156. Parving H-H, Smidt UM, Hommel E, Mathiesen ER, Rossing P, Nielsen F, Gall M-A. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy. Am J Kidney Diseases 1993; 22: 188-195.
157. Patel V, Rassam S, Newsom R, Wiek J, Kohner E. Retinal blood flow in diabetic retinopathy. Br Med J 1992; 305: 678-683
158. Pickup JC, Collins ACG, Walker JD, Viberti GC, Pasic J. Patterns of hyperinsulinaemia in type I diabetic patients with and without nephropathy. Diabetic Med 1989; 6: 685-691.
159. Rand LI, Krolewski AS, Aiello LM, Warram JA, Baker RS, Maki T. Multiple factors in the prediction of risk of proliferauve diabetic retinopathy. N Engl J Med 1985; 313: 1433-1438.
160. Reichard P, Nilsson B-Y, Rosenquist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-309.
161. Remuzzi A, Perticucci E, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 1991; 39: 1267-1273.
162. Ritz E, Fliser D. Clinical relevance of albuminuria in hypertensive patients. Clin Investig 1992; 70: 114-119.
163. Roland JM, O'Hare JP, Walthers G, Corrall RJM. Sodium retention m response to saline infusion in uncomplicated diabetes mellitus. Diabetes Res 1986; 3: 213-215.
164. Rossing P, Borch-Johnsen K, Parving H-H Risk factors for development of incipient and overt diabetic nephropathy in IDDM patients. J Am Soc Nephrol 1993; 4: 308 A.
165. Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathyan 8-year prospective study. Kidney Int 1992; 41: 822-828.
166. Rutherford PA, Thomas TH, Carr SJ, Taylor R, Wilkinson R. Changes in erythrocyte sodium-lithium counter-transport kinetics in diabetic nephropathy. Cli Sci 1992; 82: 301-307.
167. Samuelson O, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, Berglund G Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Goteborg, Sweden. J Hypertens 1985; 3: 167-176.
168. Sandeman DD, Shore AC, Tooke JE. Relation of skin capillary pressure in patients with insulin-dependent diabetes mellitus to complications and metabolic control. N Engl J Med 1992; 327: 760-764.
169. Saudek CD, Boulter PR, Knopp RH, Arky RA. Sodium retention accompanying insulin treatment of diabetes mellitus. Diabetes 1974; 23: 240-246
170. Sawicki PT, Heinemann L, Rave K. Hohmann A, Berger M. Atrial natriuretic factor in various stages of diabetic nephropathy. J Diab Compl 1988; 2: 207-209.
171. Scandling JD, Myers BD. Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease. Kidney Int 1992; 41: 840-846.
172. Schmilz A, Chnstensen CK, Christensen T, Sølling K. No microalbuminuria or other effects of long-standing hyperfiltration in humans with one kidney. Am J Kid Dis 1989; 13; 131-136.
173. Seaquist ER, Goetz FC, Rich S, Barbosa. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Eng J Med 1989; 320: 1161-1165.
174. Simonson DC. Etiologi and prevalence of hypertension in diabetic patients. Diabetes Care 1988; 11: 821-27.
175. Skptt P, Mathiesen ER, Hommel E, Gall M-A, Bruun NE, Parving H-H. The increased proximal tubular reabsorption of sodium and water is maintained in long-term insulin-dependent diabetics with early nephropathy- Scand J Clin Lab Invest 1989; 49: 419-425.
176. Skøtt P, Vaag A, Hother-Nielsen O, Andersen P, Bruun NE, Giese J, Beck-Nielsen H, Parving H-H. Effects of hyperglycemia on kidney function, atrial natriuretic factor and plasma renin in patients with insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 1991; 51: 715-727.
177. Stehouwer CDA, Nauta JJP, Zeldenrust GC, Hackeng WHL, Donker AJM, Den Ottolander GJH. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-323.
178. Stein PP, Black HR. Drug treatment of hypertension in patients with diabetes mellitus. Diabetes Care 1991; 14: 425-448.
179. Sundhedsstyrelsen. Diabetesbehandling i Danmark. 1993
180. Sundkvist G. Bergström B, Bramnert M, Lilja B, Manhem P. The activity of the renin-angiotensin-aldosteron system before and during submaximal bicycle exercise m relation to circulatory catecholamines in patients with Type 1 (insulin- dependent) diabetes mellitus. Diabetologia 1990; 33: 148-151.
181. The national high blood pressure education program coordinating committee. National high blood pressure education program working group report on ambulatory blood pressure monitoring. Arch Intern Med 1990; 150: 2270-2280.
182. The WHO multinational study of vascular disease in diabetes. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. Diabetologia 1985; 28: 615-640.
183. Trevisan R, Fioretto P, Semplicini A, Opocher G, Mantero F, Rocco S, Remuzzi G, Morocutti A, Zanette G, Donadon V, Perico N, Giorato C, Nosadini R. Role of insulin and atnal natnuretic peptide in sodium retention in insulin-treated IDDM patients during isotomc volume expansion. Diabetes 1990; 39: 289-298.
184. Viherti GC, Jarrett RJ, Mahmud U. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982, i: 1430-1432.
185. Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin dependent diabetics. Br Med J 1987; 295: 515-517.
186. Viberti GC, Mogensen CE, Groop LC, Pauls JF and the European Micoalbuminuria Captopril Study Group. Effect of captopnl on progression to clinical proteinuna in patients with insulin-dependent diabetes mellitus and microalbuminuria. JAMA 1994; 271: 275-279.
187. Walker JD, Tariq T, Viberti GC. Sodium-lithium countertransport activity in red cells of patients with insulin dependent diabetes and nephropathy and their parents. Br Med J 1990; 301 635-638.
188. Weidmann P, Bcretta-Piccoli C, Keusch G, Glück Z, Mujagic M. Meier A, Ziegler WH Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. Am J Med 1979; 67: 779-784.
189. Weidmann P, Saxenhofer H, Ferrter C, Shaw SG. Atrial natnuretic peptide in man. Am J Nephrol 1988;8:1-14. Weidmann P, Ferrari P. Central role of sodium in hypertension in diabetic subjects. Diabetes Care 1991; 14 220-232.
190. Weidmann P, Saxenhofer H, Ferrter C, Shaw SG. Atrial natnuretic peptide in man. Am J Nephrol 1988;8:1-14. Weidmann P, Ferrari P. Central role of sodium in hypertension in diabetic subjects. Diabetes Care 1991; 14 220-232.
191. WHO Expert Committee: Arterial Hypertension. Geneva, World Health Org. 1978 (Tech. Rep. Ser., no.628).
192. Wiegmann TB, Herron KG, Chonko AM, Macdougall ML, Moore WV Recognition of hypertension and abnormal blood pressure burden with ambulatory blood pressure recordings in type 1 diabetes mellitus. Diabetes 1990;39: 1556-1560.
193. Wilson DM, Luetscher JA Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med 1990; 323: 1101-1106.
194. Wiseman M, Viberti G, Mackintosh D, Jarrett RJ, Keen H. Glycaenua, arterial pressure and micro-albuminuna in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1984, 26: 401-405.
195. Yoshida Y, Fogo A, Shiraga H, Glick AD, Ichikawa I. Serial micropuncture analysis of single nephron function in subtotal renal ablation. Kidney Int 1988; 33: 855-867.
196. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as a prediction of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 1988; ii: 530-533.
197. Zatz R, Meyer TW, Renneke HG, Brenner BM. Predominance of hemodynamic rather that metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 1985; 82: 5963-5967.
198. Zatz R, Brenner BM. Pathogenesis of diabetic microangiopathy. Am J Med 1986a; 80: 443.
199. Zatz R, Dunn R, Meyer TW, Anderson S, Rennke HG, Brenner BM. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986b: 77; 1925-1930.
200. Østerby R. Glomerular structural changes in Type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diafaetologia 1992; 35: 803-812.